Fresenius SE & Co. KGaA



 


All - 2011

22.12.2011   Fresenius Medical Care enters dialysis services market in Ecuador
  PDF Text as PDF file
20.12.2011   Fresenius slightly improves outlook − Constant currency earnings growth of approximately 18% expected
  PDF Text as PDF file
20.12.2011   Fresenius Medical Care Confirms Outlook on Targeted Earnings After Tax and revises its Outlook for Full Year 2011 Revenue
  PDF Text as PDF file
14.12.2011   HELIOS completes acquisition of maximum care hospital in Duisburg, North-Rhine Westphalia
  PDF Text as PDF file
02.12.2011   Fresenius Kabi announces Changes in the Management Board
  PDF Text as PDF file
16.11.2011   Fresenius plans purchase of Fresenius Medical Care ordinary shares to preserve voting interest of at least 30%
  PDF Text as PDF file
10.11.2011   Fresenius Medical Care introduces 2008K@home™ hemodialysis delivery system in North America
  PDF Text as PDF file
02.11.2011   Fresenius achieves record Q3 earnings − improves 2011 earnings outlook
  PDF Text as PDF file
02.11.2011   Fresenius Medical Care Reports Strong Third Quarter and Nine Months Results; confirms Outlook for 2011
  PDF Text as PDF file
31.10.2011   HELIOS acquires majority of maximum care hospital in Duisburg, North-Rhine Westphalia
  PDF Text as PDF file
27.10.2011   Fresenius establishes sponsored Level I ADR Program in the United States
  PDF Text as PDF file
12.10.2011   HELIOS continues expansion in German hospital market, acquires Damp Group
  PDF Text as PDF file
10.10.2011   Fresenius Medical Care successfully raises € 100 million via issuance of floating rate senior notes
  PDF Text as PDF file
04.10.2011   Fresenius Biotech obtains reimbursement approval for Removab® antibody in Belgium
  PDF Text as PDF file
26.09.2011   Fresenius opens new production facility in Vietnam
  PDF Text as PDF file
20.09.2011   Fresenius Biotech’s Removab® receives approval for a shorter infusion time in treating malignant ascites – one-year survival rate in Removab®-treated patients is more than four times higher
  PDF Text as PDF file
08.09.2011   Fresenius Medical Care successfully places senior notes
  PDF Text as PDF file
07.09.2011   Fresenius Medical Care announces offering of senior notes
  PDF Text as PDF file
18.08.2011   Fresenius Medical Care successfully upsizes and extends accounts receivable facility
  PDF Text as PDF file
02.08.2011   Excellent sales and earnings growth − Fresenius raises earnings outlook
  PDF Text as PDF file
02.08.2011   Fresenius Medical Care Reports Strong Second Quarter and Half Year Results; confirms Outlook for 2011 and plans to acquire Liberty Dialysis as well as American Access Care
  PDF Text as PDF file
01.07.2011   Fresenius Medical Care completes acquisition of Euromedic’s dialysis service business
  PDF Text as PDF file
27.06.2011   Fresenius Medical Care announces increased effectiveness of online hemodiafiltration treatment: Studies confirm improved dialysis-patient survival
  PDF Text as PDF file
22.06.2011   Fresenius Biotech obtains reimbursement approval for Removab® antibody in Italy
  PDF Text as PDF file
07.06.2011   ASCO 2011: Fresenius Biotech presents new data for the trifunctional antibody Removab® − benefit in overall survival of cancer patients demonstrated
  PDF Text as PDF file
06.06.2011   Fresenius Biotech’s ATG-Fresenius S approved in Austria for GVHD prophylaxis in stem cell transplantations
  PDF Text as PDF file
13.05.2011   Fresenius SE & Co. KGaA annual general meeting: Health care company fully confirms short- and mid-term growth targets – 18th consecutive dividend increase
  PDF Text as PDF file
12.05.2011   Fresenius Medical Care anticipates continued strong growth − Shareholders approve 14th consecutive annual dividend increase
  PDF Text as PDF file
04.05.2011   Excellent start into 2011 − Fresenius raises 2011 sales and earnings outlook
  PDF Text as PDF file
04.05.2011   Fresenius Medical Care Reports Strong Start for 2011 and Raises Guidance for Full Year 2011
  PDF Text as PDF file
04.04.2011   Fresenius Medical Care and SEHA conclude agreement to serve dialysis patients in Abu Dhabi
  PDF Text as PDF file
17.03.2011   Fresenius Medical Care’s Patient Safety Organization Gains Official Certification by U.S. Department of Health and Human Services
  PDF Text as PDF file
08.03.2011   Fresenius Medical Care acquires Hema Metrics Crit-Line® system business
  PDF Text as PDF file
08.03.2011   Fresenius Biotech’s ATG-Fresenius S approved for GVHD prophylaxis in stem cell transplantations in Germany
  PDF Text as PDF file
23.02.2011   Fresenius: Record results in 2010 – All financial targets met or exceeded – Positive outlook for 2011
  PDF Text as PDF file
23.02.2011   Fresenius Medical Care Reports Excellent Full Year and 4th Quarter Results; Strong Outlook for 2011
  PDF Text as PDF file
28.01.2011   Fresenius successfully completes share conversion and change of legal form - First trading day of Fresenius SE & Co. KGaA shares January 31, 2011
  PDF Text as PDF file
27.01.2011   Fresenius implements share conversion and change of legal form – First trading day of Fresenius SE & Co. KGaA shares scheduled for January 31, 2011
  PDF Text as PDF file
27.01.2011   Fresenius Medical Care successfully places US$650 million and €300 million 10-year senior notes
  PDF Text as PDF file
27.01.2011   Fresenius Biotech announces agreement with Swedish Orphan Biovitrum for distribution of Removab®
  PDF Text as PDF file
21.01.2011   Fresenius Medical Care announces the offering of US$500 million and €300 million senior notes for refinancing and acquisition purposes
  PDF Text as PDF file
19.01.2011   Fresenius Medical Care awarded first contract for comprehensive dialysis care and performance-oriented reimbursement in Spain
  PDF Text as PDF file
04.01.2011   Fresenius Medical Care acquires dialysis service business from Euromedic
  PDF Text as PDF file